Garvita Gupta

Haina Qin

Jianxing Song

Luis Menéndez-Arias

Megha Haridas Upadya

Shaveta Goyal

Vincent T. K. Chow

Yee Joo Tan

PLoS ONE

PubMed

Crossref

VAPC, an Human Endogenous Inhibitor for Hepatitis C Virus (HCV) Infection, Is Intrinsically Unstructured but Forms a “Fuzzy Complex” with HCV NS5B

Goyal Shaveta

Gupta Garvita

Qin Haina

Upadya Megha Haridas

Tan Yee Joo

Chow Vincent T. K.

Song Jianxing

Public Library of Science (PLOS)

Nearly 200 million people are infected by hepatitis C virus (HCV) worldwide. For replicating the HCV genome, the membrane-associated machinery needs to be formed by both HCV non-structural proteins (including NS5B) and human host factors such as VAPB. Recently, the 99-residue VAPC, a splicing variant of VAPB, was demonstrated to inhibit HCV replication via binding to NS5B, thus acting as an endogenous inhibitor of HCV infection. So far, the structure of VAPC remains unknown, and its interaction with NS5B has not been biophysically characterized. In this study, we conducted extensive CD and NMR investigations on VAPC which led to several striking findings: 1) although the N-terminal 70 residues are identical in VAPC and VAPB, they constitute the characteristic β-barrel MSP fold in VAPB, while VAPC is entirely unstructured in solution, only with helical-like conformations weakly populated. 2) VAPC is indeed capable of binding to NS5B, with an average dissociation constant (Kd) of ∼20 µM. Intriguingly, VAPC remains dynamic even in the complex, suggesting that the VAPC-NS5B is a "fuzzy complex". 3) NMR mapping revealed that the major binding region for NS5B is located over the C-terminal half of VAPC, which is composed of three discrete clusters, of which only the first contains the region identical in VAPC and VAPB. The second region containing ∼12 residues appears to play a key role in binding since mutation of 4 residues within this region leads to almost complete loss of the binding activity. 4) A 14-residue mimetic, VAPC-14 containing the second region, only has a ∼3-fold reduction of the affinity. Our study not only provides critical insights into how a human factor mediates the formation of the HCV replication machinery, but also leads to design of VAPC-14 which may be further used to explore the function of VAPC and to develop anti-HCV molecules

Vincent T K Chow

Directory of Open Access Journals

VAPC, an human endogenous inhibitor for hepatitis C virus (HCV) infection, is intrinsically unstructured but forms a "fuzzy complex" with HCV NS5B.

A common founder for amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian population.

A diverse range of gene products are effectors of the type I interferon antiviral response.

A novel nucleolar transcriptional activator ApLLP for longterm memory formation is intrinsically unstructured but functionally active.

An overview of HCV molecular biology, replication and immune responses.

Antiviral strategies in hepatitis C virus infection.

AVAMP-binding protein from Aplysia required for neurotransmitter release.

Cellular RNA helicase p68 relocalization and interaction with the hepatitis C virus (HCV) NS5B protein and the potential role of p68 in HCV RNA replication.

Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts.

Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis.

Clinical consequences of hepatitis C virus infection.

Context is a major determinant of b-sheet propensity.

Context-dependent secondary structure formation of a designed protein sequence.

Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.

Diagnosis, management, and treatment of hepatitis C: an update.

Early steps of the hepatitis C virus life cycle.

Elimination of hepatitis C virus from hepatocytes by a selective activation of therapeutic molecules.

Elimination of the native structure and solubility of the hVAPB MSP domain by the Pro56Ser mutation that causes amyotrophic lateral sclerosis.

Epidemiology of hepatitis C: geographic differences and temporal trends.

Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics. PLoS Pathog.

Exploring the limits of nearest neighbor secondary structure prediction.

Expression and identification of hepatitis C virus polyprotein cleavage products.

Extended disordered proteins: targeting function with less scaffold.

Fuzziness: linking regulation to protein dynamics.

Fuzzy complexes: polymorphism and structural disorder in protein-protein interactions. Trends Biochem Sci.

GOR secondary structure prediction method version IV.

Hepatitis C virus resistance to protease inhibitors.

Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2.

Hepatitis C virus RNA synthesis in a cell-free system isolated from replicon-containing hepatoma cells.

How to measure and predict the molar absorption coefficient of a protein.

Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B.

Human VAPC negatively regulates hepatitis C virus propagation.

Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus.

Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein.

Incorporation of non-local interactions in protein secondary structure prediction from the amino acid sequence.

Insights into protein aggregation by NMR characterization of insoluble SH3 mutants solubilized in salt-free water.

Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft.

Intrinsically disordered protein.

Intrinsically disordered proteins are potential drug targets.

Intrinsically unstructured proteins and their functions.

Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm.

Intrinsically unstructured proteins.

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Mechanisms of hepatitis C virus infection.

Molecular cloning and characterization of mammalian homologues of vesicle-associated membrane protein-associated (VAMP-associated) proteins.

Molecular interactions of the Gb binding domain of the Ste20p/PAK family of protein kinases. An isolated but fully functional Gb binding domain from Ste20p is only partially folded as shown by heteronuclear NMR spectroscopy.

Mouse VAP33 is associated with the endoplasmic reticulum and microtubules.

New insights into HCV replication: potential antiviral targets.

New insights regarding HCV-NS5A structure/function and indication of genotypic differences.

New targets for antiviral therapy of chronic hepatitis C. Liver Int.

Newly synthesized hepatitis C virus replicon RNA is protected from nuclease activity by a protease-sensitive factor(s).

NMR evidence for forming highly populated helical conformations in the partially folded hNck2 SH3 domain.

NMR for the design of functional mimetics of proteinprotein interactions: one key is in the building of bridges.

NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

NMRView: a computer program for the visualization and analysis of NMR data.

Novel splice variants of the amyotrophic lateral sclerosis-associated gene VAPB expressed in human tissues.

Novel therapies for hepatitis C: insights from the structure of the virus.

Nuclear magnetic resonance methods for elucidation of structure and dynamics in disordered states.

Oxysterol binding protein and its homologues: New regulatory factors involved in lipid metabolism.

Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication.

Processing pathways of the hepatitis C virus proteins.

Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus.

Rational drug design via intrinsically disordered protein.

Residue-specific description of non-native transient structures in the ensemble of acid-denatured structures of the all-beta protein c-src SH3.

Selective and specific ion binding on proteins at physiologically-relevant concentrations.

Siddiqui A

Structural and dynamic characterization of an unfolded state of poplar apoplastocyanin formed under nondenaturing conditions.

Structural biology of hepatitis C virus.

Structural, stability, dynamic and binding properties of the ALS-causing T46I mutant of the hVAPB MSP domain as revealed by NMR and MD simulations.

The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors.

The N- and C-termini of the human Nogo molecules are intrinsically unstructured: bioinformatics, CD, NMR characterization, and functional implications.

The therapeutic approaches for hepatitis C virus: protease inhibitors and polymerase inhibitors.

Vesicle associated membrane protein-associated protein-A (VAP-A) interact with the oxysterol-binding protein to modify export from the endoplasmic reticulum.

http://scholarbank.nus.edu.sg/bitstream/10635/108597/1/2012-vapc_human_endogenous_inhibitor_hepatitis-published.pdf

VAPC, an human endogenous inhibitor for hepatitis C virus (HCV) infection, is intrinsically unstructured but forms a "fuzzy complex" with HCV NS5B

VAPC, an human endogenous inhibitor for hepatitis C virus (HCV) infection, is intrinsically unstructured but forms a "fuzzy complex" with HCV NS5B

Abstract

Similar works

Full text

Available Versions

Crossref

Public Library of Science (PLOS)

Directory of Open Access Journals